nference is honored to be recognized as one of the World’s Best #DigitalHealth Companies in 2024 by @Newsweek. Request a demo of our #AI software platform that is transforming healthcare by making biomedical data computable: nference.com/demo newsweek.com/rankings/worlds…

Research led by nference and @MadrigalPharma underscores the capacity of the Fibrosis-4 (FIB-4) index to forecast not only liver decompensation, but also cardiovascular events in patients with #NASH. The study highlights that a FIB-4 score as low as 1.0 can indicate significant risk for #cardiovascular events. This finding is in contrast to current guidelines which stratify FIB-4 scores less than 1.3 as low risk and scores up to 2.67 as intermediate risk. This potentially groundbreaking insight for NASH treatment was made possible by the nference AI platform, providing unparalleled access to longitudinal #patientdata from the world’s top medical centers. Leveraging nference cutting-edge language models, researchers are able to rapidly identify patients for their study populations with greater accuracy. Download the poster: images.prismic.io/nference/Z… Request a demo of the nference AI platform: nference.com/demo #Fibrosis #Liver #LanguageModels #PatientIdentification

nference language models are able to identify disease warning signs earlier than health care professionals. With our Augmented Curation #AI technology, physicians and researchers can analyze disease signs and symptoms from unstructured clinical text at scale. AL amyloidosis is an excellent example for the value of #AugmentedCuration, as it is frequently misdiagnosed due to its signs and symptoms often mimicking more-common diseases. Also know as primary #amyloidosis, this life-threatening disease results from an abnormality of plasma cells in the bone marrow and while closely related to multiple myeloma, treatment options are far less prevalent. nference collaborated with @JNJInnovMed and the @MayoClinic to study the accuracy of Augmented Curation on over 1,200 AL amyloidosis patients. Our findings demonstrate that the language model-based method matches the quality of manual curation, while being significantly more time-efficient and cost-effective. Going forward, a language model-based method for identifying signs and symptoms from clinical notes could be integrated as part of an AL amyloidosis screening or #EarlyIdentification tool. These tools could reduce the time from the initial presentation of AL amyloidosis to treatment of the disease. Read the peer-reviewed study: doi.org/10.1002/ajh.27019 Request a demo of our AI platform: nference.com/demo #LanguageModels #DiseaseDetection #RealWorldEvidence

Through advances in data science, multimodal real-world data (#RWD) is becoming an essential tool for drug developers to identify the most appropriate patients to enroll in clinical trials. With our federated AI platform, #nSights, pharma leaders gain access to millions of longitudinal patient lives across the leading medical institutions, including @MayoClinic and @DukeHealth. With this multimodal data, linked to individual patient records, researchers can rapidly compare the impact of different inclusion and exclusion criteria on patient cohorts and clinical outcomes. Learn more about the nSights platform: nference.com/nsights Request an nSights Demo: nference.com/nsights-demo-fo… #clinicaltrials #drugdevelopment #rwe #federatedlearning #ai

We were featured on the @SliceofHC podcast about the power of our federated data network! Learn how we are using multimodal data to make significant strides in life sciences. bit.ly/3t0gjEH

Thanks to the industry leaders who attended our Roundtable Discussion on unlocking the power of #RWE for the pharma lifecycle! 👏 #Healthcare #HealthTech #ClinicalTrials #MedicalAffairs #LifecycleManagement #healthcaredata #FederatedAI #RWD

During #ChildhoodCancerAwarenessMonth, we raise our voices for the brave children battling #cancer and their families. We're committed to advancing oncology research through data-driven insights and innovative technologies, with the aim of bringing hope to young patients.

Did you know that nference offers one-stop shopping for healthcare data across all therapeutic areas❓ We unlock the full potential of healthcare data to accelerate discovery and development and optimize lifecycle management. nference.com/nsights #FederatedAI

Leveraging federated data networks can increase clinical study success rates through feasibility assessments that identify patients who might benefit from the drug, leading to more efficient trials. Learn more about our #federatedAI: nference.com/pharma

nference is delighted to welcome @Vanderbilt University Medical Center to our federated network! bwnews.pr/3KbO4It #VUMC #data #FederatedAI

On #WorldLungCancerDay, we join the global community in raising awareness about #lungcancer and the need for improved treatments. nference is pioneering AI-driven approaches to accelerate lung cancer research and develop innovative therapies to improve outcomes for patients.

#WorldHepatitisDay is an opportunity to increase awareness about this devastating disease. Together, let's work towards a future with better diagnosis, treatments, and prevention. #FederatedAI

Check out this recent article in the Washington Post about the Mayo Clinic Platform's role in the AI revolution in healthcare. We are honored to collaborate with this organization to help transform healthcare. #data #healthcare #ai #FederatedAI wapo.st/3Ol7Fsl